# Sodium Phenylacetate and sodium benzoate

NDC: 68475-001
Generic name: Sodium Phenylacetate and sodium benzoate
Labeler / Manufacturer: Navinta LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20210304

FDA application: ANDA205880

## Active ingredients

- SODIUM BENZOATE: 100 mg/mL
- SODIUM PHENYLACETATE: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68475-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68475-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fbc7bfe3-6faa-45a3-befb-9ad7963c0571